Skip to main content
. 2021 Nov 9;16(11):e0259812. doi: 10.1371/journal.pone.0259812

Fig 3. Example of 20 μl Nucleocuvette™ Strip layout.

Fig 3

Experiments where (A) optimal ratio of gRNA to CRISPR/Cas protein required for precomplexing will be determined, (B) the optimal amount of recombinant CRISPR/Cas will be determined (if we assume the optimal ratio will be 1:1). All experiments will be performed in duplicate, 4 gRNAs will be used for RNP formation (AAVS1, CDK4 and HPRT1 and non-targeting control gRNA).